The stocks of VRNA have been given a rating of ‘Buy’ by close to six brokerages who have been covering the firms of the company. According to reports, one analyst has already given the stock a rating of hold, while four of them have given it a rating of buy. Just one analyst gave the company a recommendation for strong buy. The price objective set by the firm over a period of a year has been $19.44, according to the average calculated by analysts.
The Quarterly Earnings of VRNA
There have been quite a few research equities that have already commented on the stocks of VRNA. The brokerage firm Wedbush has already furnished the stocks of the company with a rating of ‘buy’ in one of their research reports that were published on the 30th of November. ValuEngine, on their part, decreased the rating of the company from a recommendation of ‘buy’ to a recommendation of ‘hold’ in a research note that was issued on the 1st of October.
The stocks of VRNA traded at $7.50 last Monday. The market cap of the company since its last trading session has been $98.75 million, with a beta fixed at 0.40, and a PE ratio of around -2.28. The debt-to-equity ratio of the company has been 0.04, with the current ratio and quick ratio fixed at 2.99. The moving average of the firm over 50-days is $7.28, while the moving average over 200-days is $6.56. The year low of the company is $2.01, while the year high is $15.71.
The stocks of VRNA previously reported their results of earnings last Thursday. The company had reported an EPS of $0.46 for the entire quarter which did beat out the consensus estimate that was set by the analysts working at Thomson Reuters.
